Arvinas to Expand Development of Resistance-Busting Cancer Drug

June 9, 2023

FDA receives application for Parkinson’s treatment by AbbVie

June 1, 2022

Novo Strikes Up to $2.1 Billion Vivtex Deal to Advance Oral Biologic Delivery for Metabolic Drugs

February 26, 2026

Must Read

FDA Expands Ionis’ Tryngolza Approval to Treat Severe Hypertriglyceridemia

June 28, 2026

Why Patient Recruitment Remains Pharma’s Most Expensive Bottleneck

June 28, 2026

EMA Committee Recommends Revoking EU Approval of Tavneos After Review of Supporting Trial Data

June 28, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Epicrispr Reports Increased Muscle Volume in Early-Stage FSHD Trial of EPI-321

cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

Definium’s LSD Formula Delivers Stunning Late-Stage Results

Merck Reports Positive Phase 3 Result for Tulisokibart in Ulcerative Colitis

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Why Patient Recruitment Remains Pharma’s Most Expensive Bottleneck

Top 10 AI Applications Transforming Pharmaceutical Market Access

The Future of Scientific Engagement in an AI-Driven World

Top 10 Data Architecture Challenges in Modern Pharma Organizations

Tag: Patient Engagement

Why Patient Recruitment Remains Pharma’s Most Expensive Bottleneck

Editor Picks

Arvinas to Expand Development of Resistance-Busting Cancer Drug

FDA receives application for Parkinson’s treatment by AbbVie

Novo Strikes Up to $2.1 Billion Vivtex Deal to Advance Oral Biologic Delivery for Metabolic Drugs

Must Read

FDA Expands Ionis’ Tryngolza Approval to Treat Severe Hypertriglyceridemia

Why Patient Recruitment Remains Pharma’s Most Expensive Bottleneck

EMA Committee Recommends Revoking EU Approval of Tavneos After Review of Supporting Trial Data

Hot Topics

About Us

Follow Us